Introducing the 2024 Porsche Cayenne S E-Hybrid SUV and Coupe
Porsche presents the third E-Hybrid variant of the Cayenne Introducing the 2024 Porsche Cayenne S E-Hybrid SUV and Coupe Porsche...
Read moreDetailsPorsche presents the third E-Hybrid variant of the Cayenne Introducing the 2024 Porsche Cayenne S E-Hybrid SUV and Coupe Porsche...
Read moreDetailsGlobal Franchisor Doubles Down on Polished Dining Segment LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.)...
Read moreDetailsNEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Planet Fitness,...
Read moreDetailsDelisting does not affect the Company’s day to day business operations or its relationships with partners or employeesDMS will continue...
Read moreDetails- The 510(k) Clearance from the United States Food and Drug Administration (FDA) allows for the U.S. commercialization of FemaSeed®,...
Read moreDetailsNEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against...
Read moreDetailsMINNETONKA, Minn., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pineapple Energy Inc. (NASDAQ: PEGY), a leading provider of sustainable solar energy...
Read moreDetailsTORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock,...
Read moreDetailsEvkeeza is a first-in-class medicine approved by Health Canada, the U.S. Food and Drug Administration (FDA) and European Commission (EC)...
Read moreDetailsAccording to a market research study published by Custom Market Insights, the demand analysis of Global Antibacterial Drugs Market size...
Read moreDetails